Response to Comment on “In Vitro and in Vivo Evaluation of a Technetium-99m-Labeled Cyclic RGD Peptide as a Specific Marker of αVβ3 Integrin for Tumor Imaging”

Abstract

ADVERTISEMENT RETURN TO ISSUEPREVArticleNEXTResponse to Comment on “In Vitro and in Vivo Evaluation of a Technetium-99m-Labeled Cyclic RGD Peptide as a Specific Marker of αVβ3 Integrin for Tumor Imaging”D. HnatowichView Author Information University of Massachusetts Medical Center Nuclear Medicine Department 55 Lake Avenue North Worcester, Massachusetts 01655 %E-mail: [email protected] Cite this: Bioconjugate Chem. 2003, 14, 2, 275Publication Date (Web):February 28, 2003Publication History Published online28 February 2003Published inissue 1 March 2003https://doi.org/10.1021/bc020085oCopyright © 2003 American Chemical SocietyRIGHTS & PERMISSIONSArticle Views91Altmetric-Citations-LEARN ABOUT THESE METRICSArticle Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated. Share Add toView InAdd Full Text with ReferenceAdd Description ExportRISCitationCitation and abstractCitation and referencesMore Options Share onFacebookTwitterWechatLinked InReddit Read OnlinePDF (18 KB) Get e-AlertsSUBJECTS:Biological imaging,Peptides and proteins,Receptors,Screening assays,Tumors Get e-Alerts